Epigenome’s role in cancer revealed in new study
Scientists at the School of Medicine have analyzed the epigenomes of tumor cells across 11 cancer types and revealed important roles for this regulatory system of the genome in the way cancer forms, grows and spreads.
Pancreatic cancer research, clinical trials supported with $10.9 million NCI grant
Researchers at the School of Medicine have received a prestigious grant from the National Cancer Institute of the National Institutes of Health (NIH) to support research and clinical trials aimed at improving therapies for pancreatic cancer.
Noninvasive, ultrasound-based brain biopsy is feasible, safe in people
Researchers at the School of Medicine and the McKelvey School of Engineering have developed a noninvasive technique called sonobiopsy that uses ultrasound and microbubbles to release biomolecules from brain tumors. A blood draw can collect the biomolecules to help inform treatment decisions.
$5 million for research on immune responses to cancer-causing virus in immunocompromised kids
Researchers at the School of Medicine have received a $5.7 million grant from the National Cancer Institute of the National Institutes of Health (NIH) to investigate immune responses to a cancer-causing virus after organ transplantation in children.
Choi, Pachynski receive research scholar awards
Jaebok Choi, PhD, and Russell Pachynski, MD, both of the School of Medicine, have received Research Scholar Grants from the American Cancer Society to support their research in oncology. Both investigators are research members of Siteman Cancer Center at Barnes-Jewish Hospital and the School of Medicine.
$11.6 million grant supports innovative research in endometrial cancer
Led by principal investigator David Mutch, MD, researchers at the School of Medicine have received a prestigious Specialized Programs of Research Excellence (SPORE) grant in endometrial cancer from the National Cancer Institute of the National Institutes of Health (NIH).
Medicare approves WashU Medicine’s whole-genome test for blood cancers
A new test for two blood cancers — developed by a team at the School of Medicine — is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services.
Scientists reveal how proteins drive growth of multiple cancer types
Led by the School of Medicine and other institutions around the world, the Clinical Proteomic Tumor Analysis Consortium has completed a deep analysis of the proteins driving cancer across multiple tumor types. The findings could help lead to new therapies.
Siteman earns prestigious merit extension from National Cancer Institute
Siteman Cancer Center, based at Barnes-Jewish Hospital and the School of Medicine, has earned a prestigious Merit Extension Award from the National Cancer Institute (NCI), recognizing continued excellence in cancer care, research, training, prevention and community outreach.
First robotic liver transplant in U.S. performed by Washington University surgeons
A surgical team from the School of Medicine recently performed the first robotic liver transplant in the U.S. in May at Barnes-Jewish Hospital.
Older Stories